FN2 Earnings Intelligence
The Procter & Gamble Company balance sheet
The Procter & Gamble Company (PG) Balance Sheet (annual) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 6/30/2021 | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 | 6/30/2026 est. | 6/30/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $10,288 | $7,214 | $8,246 | $9,482 | $9,556 | - | - |
| + Debt | $31,988 | $31,493 | $34,607 | $32,460 | $34,508 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $76,118 | $80,187 | $82,006 | $84,039 | $84,284 | $87,130.8 | $89,374.7 |
| % Growth | 7.3% | 5.3% | 2.3% | 2.5% | 0.3% | 3.4% | 2.6% |
| Gross Profit | $39,010 | $38,030 | $39,246 | $43,191 | $43,120 | - | - |
| % Margin | 51.2% | 47.4% | 47.9% | 51.4% | 51.2% | - | - |
| EBITDA | $20,721 | $20,620 | $20,848 | $21,441 | $23,298 | - | - |
| % Margin | 27.2% | 25.7% | 25.4% | 25.5% | 27.6% | - | - |
| Net Income | $14,306 | $14,742 | $14,653 | $14,879 | $15,974 | - | - |
| % Margin | 18.8% | 18.4% | 17.9% | 17.7% | 19.0% | - | - |
| Diluted EPS | $5.50 | $5.81 | $5.90 | $6.02 | $6.51 | $6.88 | $7.02 |
| % Growth | 10.9% | 5.6% | 1.5% | 2.0% | 8.1% | 5.6% | 2.1% |
| Operating Cash Flow | $18,371 | $16,723 | $16,848 | $19,846 | $17,817 | - | - |
| CapEx | $2,787 | $3,156 | $3,062 | $3,322 | $3,773 | - | - |
| Free Cash Flow | $15,584 | $13,567 | $13,786 | $16,524 | $14,044 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 6/30/2021 | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 | 6/30/2026 est. | 6/30/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $76,118 | $80,187 | $82,006 | $84,039 | $84,284 | $87,130.8 | $89,374.7 |
| Gross Profit | $39,010 | $38,030 | $39,246 | $43,191 | $43,120 | - | - |
| EBITDA | $20,721 | $20,620 | $20,848 | $21,441 | $23,298 | - | - |
| Net Income | $14,306 | $14,742 | $14,653 | $14,879 | $15,974 | - | - |
| Diluted EPS | $5.50 | $5.81 | $5.90 | $6.02 | $6.51 | $6.88 | $7.02 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 6/30/2021 | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $10,288 | $7,214 | $8,246 | $9,482 | $9,556 |
| Short-term Debt | $8,889 | $8,645 | $10,229 | $7,191 | $9,513 |
| Long-term Debt | $23,099 | $22,848 | $24,378 | $25,269 | $24,995 |
| Total Debt | $31,988 | $31,493 | $34,607 | $32,460 | $34,508 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 6/30/2021 | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $18,371 | $16,723 | $16,848 | $19,846 | $17,817 |
| Capital Expenditure | $2,787 | $3,156 | $3,062 | $3,322 | $3,773 |
| Free Cash Flow | $15,584 | $13,567 | $13,786 | $16,524 | $14,044 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 6/30/2021 | 6/30/2022 | 6/30/2023 | 6/30/2024 | 6/30/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 7.3% | 5.3% | 2.3% | 2.5% | 0.3% |
| Gross Margin | 51.2% | 47.4% | 47.9% | 51.4% | 51.2% |
| EBITDA Margin | 27.2% | 25.7% | 25.4% | 25.5% | 27.6% |
| Net Margin | 18.8% | 18.4% | 17.9% | 17.7% | 19.0% |
| FCF Margin | 20.5% | 16.9% | 16.8% | 19.7% | 16.7% |
| Diluted EPS Growth | 10.9% | 5.6% | 1.5% | 2.0% | 8.1% |